•
Jun 30, 2021

Soleno Therapeutics Q2 2021 Earnings Report

EPS
-$2.1
Previous year: -$2.4
-12.5%
Cash and Equivalents
$33.6M
Free Cash Flow
-$8.01M
Total Assets
$48.8M

Soleno Therapeutics

Soleno Therapeutics